Quarterly Earnings Supplement Q4 2024 Total Subscription Revenue Growth Product Offerings Subscription Segment Trupanion Core North America Other Subscription Products North America PHI Direct Furkin Chewy Aflac Other Subscription Products International PetExpert* (Czechia, Slovakia, Belgium, Poland) Smart Paws (Germany, Switzerland) Other Business Segment Pets Best Veteran Affairs Service Dog Program Legacy Worksite Benefits (Corporate & Veterinary Hospital) Aquarium Technology *Managing General Agents (in ...

Q4 2024 & Annual Earnings Slides // February 19, 2025 Forward-Looking Statements Certain statements contained in this presentation include, and OPENLANE may make related oral, "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. In particular, statements made that are not historical facts (including but not limited to expectations, estimates, assumptions, projections and/or financial guidance) may be forward-looking statements. Words such as "should," "may ...

Q4 AND 2024 EARNINGS RESULTS February 19, 2025 New CEO Juho Sarvikas | Leadership Rooted in Wireless Innovation On January 6, 2025, Juho Sarvikas, the former President of Qualcomm North America joined Inseego as CEO and board member. Proven Leadership in Wireless Technology – As CEO, Juho Sarvikas brings a strategic vision focused on leveraging engineering excellence to drive technology and product leadership in the wireless market. Extensive Global Executive Experience – Over two decades of expertise in st ...

I N V E S T O R P R E S E N T A T I O N F E B R U A R Y 2 0 2 5 F O R W A R D - L O O K I N G S T A T E M E N T S This presentation contains "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 or "forward-looking information" within the meaning of Canadian securities laws that are based on IMAX management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future ...

Investor Presentation Fourth Quarter 2024 Earnings February 19, 2025 1 February 2025 / © 2025 Remitly Inc. Disclosures Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements. These statements include, but are not limited to, statements regarding our future results of operations and financial position, including our fiscal ...

Our purpose is to help eradicate cancer by preventing it, detecting it earlier, and guiding personalized treatment. Fourth-quarter 2024 earnings call February 19, 2025 Proprietary scientific platform detects cancer earlier and accurately EXACT SCIENCES 1 Safe harbor and non-GAAP disclosures This presentation contains forward-looking statements concerning our expectations, anticipations, intentions, beliefs or strategies regarding the future. These forward-looking statements are based on assumptions that we ...

Q4-24 EARNINGS PRESENTATION FEB_19_2025 FORWARD LOOKING STATEMENTS Statements in this presentation regarding future performance and future expectations, beliefs, goals, plans or prospects include forward looking statements for purposes of federal and state securities laws, including statements regarding ACV's avenues for long term growth and total addressable market expansion, our financial guidance for the first quarter and full year of 2025, and operational and product strategy. Any statements that are no ...

Investor Presentation February 2025 Safe Harbor Statement Forward-Looking Statements This presentation contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, including, without limitation, statements regarding our ability to build and scale our advanced silicon-anode lithium-ion battery; our production and commercialization timeline; our ability to meet milestones and deliver on our objectives and expectations; our ability to maintain a comp ...

Fourth Quarter 2024 Earnings February 19, 2025 BioMarin regularly uses both GAAP and Non-GAAP results and expectations internally to assess its financial operating performance and evaluate key business decisions related to its principal business activities: the discovery, development, manufacture, marketing and sale of innovative biologic therapies. Because Non- GAAP Income, Non-GAAP Operating Margin percentage, Non-GAAP Diluted EPS, and Non-GAAP Weighted-Average Diluted Shares Outstanding are important int ...

Investor Presentation February 2025 Disclaimer 2 This presentation includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements give our current expectations or forecasts of future events. These statements include estimates of future natural gas and oil reserves, expected natural gas and oil production and future expenses, assumptions regarding future natural gas and oil prices, budget ...